ID   Z518A_RAT               Reviewed;        1478 AA.
AC   Q499R0;
DT   02-SEP-2008, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2005, sequence version 1.
DT   29-MAY-2024, entry version 131.
DE   RecName: Full=Zinc finger protein 518A;
GN   Name=Znf518a; Synonyms=Zfp518, Zfp518a, Znf518;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Through its association with the EHMT1-EHMT2/G9A and
CC       PRC2/EED-EZH2 histone methyltransferase complexes may function in gene
CC       silencing, regulating repressive post-translational methylation of
CC       histone tails at promoters of target genes.
CC       {ECO:0000250|UniProtKB:B2RRF6}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:B2RRF6}.
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC099801; AAH99801.1; -; mRNA.
DR   RefSeq; NP_001025209.1; NM_001030038.1.
DR   RefSeq; XP_006231459.1; XM_006231397.3.
DR   RefSeq; XP_006231460.1; XM_006231398.3.
DR   RefSeq; XP_008758662.1; XM_008760440.2.
DR   RefSeq; XP_017444785.1; XM_017589296.1.
DR   AlphaFoldDB; Q499R0; -.
DR   STRING; 10116.ENSRNOP00000051600; -.
DR   CarbonylDB; Q499R0; -.
DR   iPTMnet; Q499R0; -.
DR   PhosphoSitePlus; Q499R0; -.
DR   PaxDb; 10116-ENSRNOP00000051600; -.
DR   Ensembl; ENSRNOT00000054717.4; ENSRNOP00000051600.2; ENSRNOG00000036592.4.
DR   Ensembl; ENSRNOT00000097947.1; ENSRNOP00000092189.1; ENSRNOG00000036592.4.
DR   Ensembl; ENSRNOT00000098938.1; ENSRNOP00000096129.1; ENSRNOG00000036592.4.
DR   Ensembl; ENSRNOT00000105629.1; ENSRNOP00000095709.1; ENSRNOG00000036592.4.
DR   Ensembl; ENSRNOT00000111652.1; ENSRNOP00000080397.1; ENSRNOG00000036592.4.
DR   Ensembl; ENSRNOT00055051675; ENSRNOP00055042616; ENSRNOG00055029815.
DR   Ensembl; ENSRNOT00055051686; ENSRNOP00055042625; ENSRNOG00055029815.
DR   Ensembl; ENSRNOT00055051700; ENSRNOP00055042639; ENSRNOG00055029815.
DR   Ensembl; ENSRNOT00055051708; ENSRNOP00055042646; ENSRNOG00055029815.
DR   Ensembl; ENSRNOT00055051716; ENSRNOP00055042654; ENSRNOG00055029815.
DR   Ensembl; ENSRNOT00060048110; ENSRNOP00060040035; ENSRNOG00060027708.
DR   Ensembl; ENSRNOT00060048134; ENSRNOP00060040057; ENSRNOG00060027708.
DR   Ensembl; ENSRNOT00060048142; ENSRNOP00060040063; ENSRNOG00060027708.
DR   Ensembl; ENSRNOT00060048153; ENSRNOP00060040072; ENSRNOG00060027708.
DR   Ensembl; ENSRNOT00060048167; ENSRNOP00060040086; ENSRNOG00060027708.
DR   Ensembl; ENSRNOT00065047537; ENSRNOP00065039005; ENSRNOG00065027562.
DR   Ensembl; ENSRNOT00065047556; ENSRNOP00065039012; ENSRNOG00065027562.
DR   Ensembl; ENSRNOT00065047566; ENSRNOP00065039020; ENSRNOG00065027562.
DR   Ensembl; ENSRNOT00065047582; ENSRNOP00065039031; ENSRNOG00065027562.
DR   Ensembl; ENSRNOT00065047593; ENSRNOP00065039040; ENSRNOG00065027562.
DR   GeneID; 309478; -.
DR   KEGG; rno:309478; -.
DR   UCSC; RGD:1305314; rat.
DR   AGR; RGD:1305314; -.
DR   CTD; 72672; -.
DR   RGD; 1305314; Zfp518a.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000162006; -.
DR   HOGENOM; CLU_005711_0_0_1; -.
DR   InParanoid; Q499R0; -.
DR   OMA; TYYQNIQ; -.
DR   OrthoDB; 3593389at2759; -.
DR   PhylomeDB; Q499R0; -.
DR   TreeFam; TF332842; -.
DR   PRO; PR:Q499R0; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000036592; Expressed in thymus and 19 other cell types or tissues.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 2.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR24392; ZINC FINGER PROTEIN; 1.
DR   PANTHER; PTHR24392:SF39; ZINC FINGER PROTEIN 518A; 1.
DR   SMART; SM00355; ZnF_C2H2; 7.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 2.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 1.
PE   2: Evidence at transcript level;
KW   Chromatin regulator; DNA-binding; Isopeptide bond; Metal-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..1478
FT                   /note="Zinc finger protein 518A"
FT                   /id="PRO_0000349266"
FT   ZN_FING         152..174
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         209..231
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         236..258
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         264..287
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         1444..1466
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          355..394
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          464..484
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          656..694
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        363..386
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        658..694
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         652
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6AHZ1"
FT   CROSSLNK        358
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q6AHZ1"
FT   CROSSLNK        390
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q6AHZ1"
FT   CROSSLNK        428
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q6AHZ1"
FT   CROSSLNK        518
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q6AHZ1"
FT   CROSSLNK        707
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q6AHZ1"
FT   CROSSLNK        792
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q6AHZ1"
FT   CROSSLNK        882
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q6AHZ1"
FT   CROSSLNK        895
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q6AHZ1"
FT   CROSSLNK        987
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q6AHZ1"
FT   CROSSLNK        1008
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q6AHZ1"
FT   CROSSLNK        1041
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q6AHZ1"
FT   CROSSLNK        1055
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q6AHZ1"
FT   CROSSLNK        1078
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q6AHZ1"
FT   CROSSLNK        1180
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q6AHZ1"
FT   CROSSLNK        1441
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q6AHZ1"
SQ   SEQUENCE   1478 AA;  165539 MW;  7D5A04C646980C6F CRC64;
     MPFEQTQLFC DEKQTILKKI DTRNEIPDTI KSIPIPKISE AGFHYEPKNV NICLPKINIP
     NEILMKHEVE KYRKLFQSKP QTARKSVSVR TVSCAKGCAQ RCESERAEDE AGKMCAKILN
     FTCSKCQDRT QYSPNDLQKH FEMWHHGELP SFPCEMCSFS ASDFQIFKQH RKTHRNTFVK
     CDICNSERSY TLLDLTKHFT SKHCVNGNFQ CEECRFFTQD VGTFVQHIHR HKEVHYKCGK
     CHHLCFTKGE LQKHLRVHSG TLPFTCHYCS YGAIHKDQLV RHVITLHKEH LYAKEKLERD
     QYDKRVAKTT TGLKLILKRY KIGPTKTFWK RKTIASGNDE SIGKNAQAFN IVSKTQTKSE
     DQSQEQLNEE KGGRQHCEDG DKPIESGSEK ATVLSTGQCN KADEGASAPS SVLSAVQGPT
     VLLVRNNKIT IPANYSAKFM GFKMVDGRQH IVIKLLPANK QILPSPALQP NTEKESTANL
     PPQAMDNTGF ATGLTAMNDT DFVKAAPLSC SSPELPRKVI SEKETAFISE KNNMLQMVDD
     SKSVTSLPTP SESVTSVRLT TKVEARDNVD LWENPSTQSH PDLIGTSINS PDKVNLTIRP
     NAYSCGDMHN YCINYVNSEL PAESSNCFEF SNQGSLPFHN YSKVNNKRRR FSRGAVCENL
     QRESSNKTVT QQSTSDSDTT SPLRKESSNS DSLLASISPL SGTLKIKTEI EEPCDLEETQ
     NFNEQSLFTN ENQNLLNMTE EPKWDDIPCA GSPMMPRITS VFSLQSEQAS EFLPPEVNQL
     LQDTLKPRSD IKEDSNNIPS KNLPLDCDQT LKKSKEEVIK SSKDFQMQDI ISVPSASVGV
     NVPANDLNLK CNGQEKQALS VLQDVRDPGV TTKIPSIITL LKTQSDAIIT QQLVKDKLRT
     TTQHSGPVYV QNPLLTSEQK NPVFVQTPKG FIIPLHVANK PGLHVFSGRP VPLVNTQSVP
     AALLVNKKPG VVLTVNNGKP EGVPTVKTEN VHSYGTVTKE PCRTPFLKAE HNRYCLTPGL
     CSSIGSCVNM KTCSENTLPL KGSYIIKTSV SSSVKAVPFA NVLPEQQGPN VNVLDAVKQQ
     NESLPKASLY TLMPDGKQAV FFKCMMPNNT KLLKPRLVQN STYQRIQPKR PAGAPQKILL
     KIFNPVLSMS AVNNLSVGNS ASSFQKEIVP SKPTVHGEQK VPQSSRDALP VSVQDLMPAN
     EAVLSSTAAC PGSSEEPVHI SERSETRVSR SKANCTIERN FNKRKTCKNK FAKIKTRISQ
     DSETAFVSRN RSCKRKYIDN YQEPPRKKSA THRKCKERAN AEDVQETFGF SRPRLPKDSG
     RTLRLFPFNS EQLVKCPRRN QPVVVLNHPD ADAPEVERVM KTITKFNGRV LKVSLSKATI
     NALLKPVSIT SETTYSDFSK RHKMLKPVNS VKERFVLKLT LKKTSKNNYQ IVKTTSEDVL
     KSKFNCWFCG RVFDNQDVWA GHGQRHLVEA TKDWNMLE
//
